Document is current
Any future updates will be listed below
-
Authors
Stewart, C. Andrew https://orcid.org/0000-0001-7936-447X
Daniel, Shaji
Curvino, Elizabeth J. https://orcid.org/0000-0003-4452-0457
Zhang, Yi
Kamboh, Hafsa
Sergueev, Kirill
Casi, Minhtran N.
Chowdhury, Adam https://orcid.org/0009-0006-4794-6751
Xu, Heng
Li, Youqiang
Tosun, Mehmet
Duvernay, Matthew T.
Shan, Yufei
Djigal, Mame
Kireeva, Maria
Biaksangi, Jennifer L.
Glassband, Taylor
Altuntas, Fevzi
Yiğenoğlu, Tuğçe Nur
Boccia, Ralph
Bardeja, Jesus
Wangjam, Tamna
Singer, Michael S.
Kalayoglu, Murat V.
Kurtoglu, Metin
Benson, Albina
English, Emily P. https://orcid.org/0009-0000-1621-4669
Tostanoski, Lisa H. https://orcid.org/0000-0001-9255-5684
Miljkovic, Milos D. https://orcid.org/0000-0001-5848-6320
Jewell, Christopher M. https://orcid.org/0000-0002-6668-6928
- License Information
-
More Information
Article History
Received: 21 December 2023
Accepted: 1 October 2025
First Online: 28 November 2025
Competing interests
: C.A.S., S.D., E.J.C., Y.Z., H.K., K.S., M.N.C., A.C., H.X., Y.L., M.T., M.T.D., Y.S., M.D., M.K., J.L.B., T.G., M.S.S., M.V.K., M.K., A.B., E.P.E., L.H.T., M.D.M. and C.M.J. are employees of and/or hold equity in Cartesian Therapeutics. C.M.J. is appointed as a professor at the University of Maryland and a research health scientist at the VA Maryland Health Care System. The views in this paper do not reflect the views of the state of Maryland or the United States Government. C.M.J. is founder of Nodal Therapeutics and holds equity positions with Nodal Therapeutics and Barinthus Biotherapeutics. J.B.’s institution receives research funds in their name from AstraZeneca, BMS, C4 Therapeutics, Caribou Biosciences, CARsgen, Cartesian Therapeutics, Genentech, GSK, Gracell, Ichnos Sciences, J&J, Juno Therapeutics, K36 Therapeutics, Karyopharm, Kite, Moderna, Pfizer, Regeneron, Roche and Sanofi. J.B. is a consultant for AstraZeneca, BMS, Galapagos, Genentech, J&J, Karyopharm, Kite Pharma, Kyowa Kirin, Pfizer, Regeneron, Roche and Sebia. J.B. has received a speaker honorarium from Janssen. No other conflicts are declared.
